Polymorphism of cytochrome P-450 in humans
- 1 March 1989
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 10 (3) , 107-109
- https://doi.org/10.1016/0165-6147(89)90207-1
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Characterization of Human Microsomal Cytochrome P-450 EnzymesAnnual Review of Pharmacology and Toxicology, 1989
- Characterization of cDNAs, mRNAs, and proteins related to human liver microsomal cytochrome P-450 S-mephenytoin 4-hydroxylaseBiochemistry, 1988
- Lack of bimodality in nifedipine plasma kinetics in a large population of healthy subjectsBiochemical Pharmacology, 1988
- Characterization of the common genetic defect in humans deficient in debrisoquine metabolismNature, 1988
- Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populationsClinical Pharmacology & Therapeutics, 1985
- Metabolic oxidation phenotypes as markers for susceptibility to lung cancerNature, 1984
- Inherited Defects of Hepatic Drug MetabolismSeminars in Liver Disease, 1983
- Pharmacogenetics of tolbutamide metabolism in humansDiabetes, 1979
- POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MANThe Lancet, 1977
- Effect of rifampicin.treatment on the metabolism of oestradiol and 17?-ethinyloestradiol by human liver microsomesEuropean Journal of Clinical Pharmacology, 1975